Ontology highlight
ABSTRACT:
SUBMITTER: McWilliam SJ
PROVIDER: S-EPMC7000680 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
McWilliam Stephen J SJ Rosala-Hallas Anna A Jones Ashley P AP Shaw Victoria V Greenhalf William W Jaki Thomas T Smyth Alan R AR Smyth Rosalind L RL Pirmohamed Munir M
Scientific reports 20200204 1
The PROteKT study tested the hypothesis that rosuvastatin can inhibit aminoglycoside-induced nephrotoxicity in children with Cystic Fibrosis (CF). This open label, parallel group, randomised controlled trial recruited children and young people aged 6 to 18 years with CF at 13 paediatric CF treatment centres in the UK. Participants were randomised equally to either receive oral rosuvastatin (10 mg once daily) or no intervention (control) throughout clinically indicated treatment with intravenous ...[more]